Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based...
| Autor: | Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker JS, Luo J, Deschryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Watson MA, Leitch M, Hunt K, Olson JA |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 6/10/2011, Vol. 29 Issue 17, p2342-2349, 8p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|